{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,20]],"date-time":"2026-01-20T06:37:17Z","timestamp":1768891037837,"version":"3.49.0"},"reference-count":38,"publisher":"Oncology Nursing Society (ONS)","issue":"3","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["CJON"],"published-print":{"date-parts":[[2022,6,1]]},"DOI":"10.1188\/22.cjon.313-317","type":"journal-article","created":{"date-parts":[[2022,5,23]],"date-time":"2022-05-23T11:39:29Z","timestamp":1653305969000},"page":"313-317","source":"Crossref","is-referenced-by-count":5,"title":["Hypomagnesemia and Hypokalemia: Considerations for Cancer Care"],"prefix":"10.1188","volume":"26","author":[{"given":"Jismon","family":"Kuruppath","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Puja","family":"Patel","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1302","published-online":{"date-parts":[[2022,6,1]]},"reference":[{"key":"1","doi-asserted-by":"crossref","unstructured":"Ayuk, J., & Gittoes, N.J.L. (2014). Treatment of hypomagnesemia. American Journal of Kidney Diseases, 63(4), 691\u2013695.","DOI":"10.1053\/j.ajkd.2013.07.025"},{"key":"2","unstructured":"Bayer Healthcare. (2014). Phillips Milk of Magnesia\u00ae (magnesium hydroxide). [Package Insert]."},{"key":"3","unstructured":"Brown, C.G. (Ed.). (2015). Electrolyte imbalances, SIADH, and tumor lysis syndrome. In A guide to oncology symptom management (2nd ed., pp. 320\u2013368). Oncology Nursing Society."},{"key":"4","unstructured":"Chernecky, C., & Murphy-Ende, K. (2009). Acute care oncology nursing. Elsevier."},{"key":"5","unstructured":"Firoz, M., & Graber, M. (2001). Bioavailability of US commercial magnesium preparations. Magnesium Research, 14(4), 257\u2013262."},{"key":"6","unstructured":"Flurie, R.W. (2020). Disorders of potassium and magnesium homeostasis. In J.T. DiPiro, G.C. Yee, L. Posey, S.T. Haines, T.D. Nolin, & V. Ellingrod (Eds.), Pharmacotherapy: A pathophysiologic approach (11th ed.). McGraw Hill. https:\/\/bit.ly\/3vWEDWC"},{"key":"7","unstructured":"GlaxoSmithKline Consumer Healthcare Holdings. (2011). Gaviscon\u00ae (magnesium carbonate). [Package insert]."},{"key":"8","unstructured":"Global RPH. (2017). Magnesium Supplements. https:\/\/globalrph.com\/drugs\/magnesium -supplements\/"},{"key":"9","unstructured":"Guerrera, M.P., Volpe, S.L., & Mao, J.J. (2009). Therapeutic uses of magnesium. American Family Physician, 80(2), 157\u2013162."},{"key":"10","doi-asserted-by":"crossref","unstructured":"Huang, C.L., & Kuo, E. (2007). Mechanism of hypokalemia in magnesium deficiency. Journal of the American Society of Nephrology, 18(10), 2649\u20132652.","DOI":"10.1681\/ASN.2007070792"},{"key":"11","doi-asserted-by":"crossref","unstructured":"Kraft, M.D., Btaiche, I.F., Sacks, G.S., & Kudsk, K.A. (2005). Treatment of electrolyte disorders in adult patients in the intensive care unit. American Journal of Health-System Pharmacy, 62(16), 1663\u20131682.","DOI":"10.2146\/ajhp040300"},{"key":"12","unstructured":"Kuhn, I., Jost, V., Wieckhorst, G., Theiss, U., & L\u00fccker, P.W. (1992). Renal elimination of magnesium as a parameter of bioavailability of oral magnesium therapy. Methods and Findings in Experimental and Clinical Pharmacology, 14(4), 269\u2013272."},{"key":"13","unstructured":"Lewis, J.L., III. (2021a). Endocrine and metabolic disorders: Hypokalemia. Merck. https:\/\/bit .ly\/3wfpGxH"},{"key":"14","unstructured":"Lewis, J.L., III. (2021b). Endocrine and metabolic disorders: Hypomagnesemia. Merck. https:\/\/bit.ly\/3N5F3zK"},{"key":"15","unstructured":"Lexicomp. (2021a). Magnesium L-aspartate hydrochloride: Drug information. UpToDate. Retrieved April 15, 2022, from https:\/\/bit.ly\/3yovCas"},{"key":"16","unstructured":"Lexicomp. (2021b). Magnesium sulfate: Drug information. UpToDate. Retrieved April 15, 2022 from https:\/\/bit.ly\/3FEFfTV"},{"key":"17","unstructured":"Lexicomp. (2022a). Magnesium chloride: Drug information. UpToDate. Retrieved April 15, 2022, from https:\/\/bit.ly\/3yt1Scs"},{"key":"18","unstructured":"Lexicomp. (2022b). Magnesium Gluconate: Drug Information. UpToDate. Retrieved April 15, 2022, fromhttps:\/\/bit.ly\/3N1toSg"},{"key":"19","unstructured":"Lexicomp. (2022c). Magnesium L-lactate: Drug Information. UpToDate. Retrieved April 15, 2022 from https:\/\/bit.ly\/3PdShMM"},{"key":"20","unstructured":"Mag-tab SR. (2022). Formulation and comparison. https:\/\/www.magtabsr.com\/"},{"key":"21","unstructured":"Meijer Distribution. (2022). Citroma\u00ae (magnesium citrate). [Package insert]."},{"key":"22","unstructured":"Mount, D.B. (2018). Hypokalemia. In J. Jameson, A.S. Fauci, D.L. Kasper, S.L. Hauser, D.L. Longo, & J. Loscalzo (Eds.), Harrison\u2019s principles of internal medicine (20th ed.). McGraw Hill."},{"key":"23","unstructured":"National Cancer Institute Cancer Therapy Evaluation Program. (2017). Common terminology criteria for adverse events [v.5.0]. https:\/\/bit.ly\/39addDx"},{"key":"24","unstructured":"National Institutes of Health Office of Dietary Supplements. (2021a). Magnesium fact sheet for healthcare professionals. https:\/\/ods.od.nih.gov\/factsheets\/MagnesiumHealthProfessional"},{"key":"25","unstructured":"National Institutes of Health Office of Dietary Supplements. (2021b). Potassium fact sheet for healthcare professionals. https:\/\/ods.od.nih.gov\/factsheets\/PotassiumHealthProfessional"},{"key":"26","doi-asserted-by":"crossref","unstructured":"Oronsky, B., Caroen, S., Oronsky, A., Dobalian, V.E., Oronsky, N., Lybeck, M., . . . Carter, C.A. (2017). Electrolyte disorders with platinum-based chemotherapy: Mechanisms, manifestations, and management. Cancer Chemotherapy and Pharmacology, 80(5), 895\u2013907.","DOI":"10.1007\/s00280-017-3392-8"},{"key":"27","doi-asserted-by":"crossref","unstructured":"Pabla, N., & Dong, Z. (2008). Cisplatin nephrotoxicity: Mechanisms and renoprotective strategies. Kidney International, 73(9), 994\u20131007.","DOI":"10.1038\/sj.ki.5002786"},{"key":"28","doi-asserted-by":"crossref","unstructured":"Perazella, M.A. (2012). Onco-nephrology: Renal toxicities of chemotherapeutic agents. Clinical Journal of the American Society of Nephrology, 7(10), 1713\u20131721.","DOI":"10.2215\/CJN.02780312"},{"key":"29","unstructured":"Pharmacist\u2019s Letter. (2011). Comparison of Oral Magnesium Salts. https:\/\/bit.ly\/3N3vcKB"},{"key":"30","unstructured":"Prestige Consumer Healthcare. (2022a). Mag-Ox 400\u00ae (magnesium oxide) [Package insert]."},{"key":"31","unstructured":"Prestige Consumer Healthcare. (2022b). Uro-Mag\u00ae (magnesium oxide) [Package insert]."},{"key":"32","doi-asserted-by":"crossref","unstructured":"Ranade, V.V., & Somberg, J.C. (2001). Bioavailability and pharmacokinetics of magnesium after administration of magnesium salts to humans. American Journal of Therapeutics, 8(5), 345\u2013357.","DOI":"10.1097\/00045391-200109000-00008"},{"key":"33","doi-asserted-by":"crossref","unstructured":"Reed, B.N., Zhang, S., Marron, J.S., & Montague, D. (2012) Comparison of intravenous and oral magnesium replacement in hospitalized patients with cardiovascular disease. American Journal of Health-System Pharmacy, 69(14), 1212\u20131217.","DOI":"10.2146\/ajhp110574"},{"key":"34","unstructured":"Roller, L.K., Baumgartner, L., & Desselle, S.P. (Eds.). (2019). Hypomagnesemia. Quick answers: Pharmacy. McGraw Hill. https:\/\/bit.ly\/3Pmub2q"},{"key":"35","doi-asserted-by":"crossref","unstructured":"Rosner, M.H., & Dalkin, A.C. (2014). Electrolyte disorders associated with cancer. Advances in Chronic Kidney Disease, 21(1), 7\u201317.","DOI":"10.1053\/j.ackd.2013.05.005"},{"key":"36","unstructured":"Upsher-Smith Laboratories. (2019). Klor-Con\u00ae (potassium chloride) [Package insert]."},{"key":"37","unstructured":"Wellspring Pharmaceutical. (2016). Gelusil\u00ae (aluminum hydroxide, magnesium hydroxide, simethicone). [Package insert]."},{"key":"38","unstructured":"Yu, A.S.L., BChir, M.B., & Yarlagadda, S.G. (2021). Hypomagnesemia: Clinical manifestations of magnesium depletion. In A.Q. Lam (Ed.), UpToDate. Retrieved April 11, 2022, from https:\/\/www .uptodate.com\/contents\/hypomagnesemia-clinical-manifestations-of-magnesium -depletion"}],"container-title":["Clinical Journal of Oncology Nursing"],"original-title":[],"link":[{"URL":"http:\/\/cjon.ons.org\/cjon\/26\/3\/hypomagnesemia-and-hypokalemia-considerations-cancer-care","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,11,21]],"date-time":"2025-11-21T19:48:56Z","timestamp":1763754536000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.ons.org\/publications-research\/cjon\/26\/3\/hypomagnesemia-and-hypokalemia-considerations-cancer-care"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,6,1]]},"references-count":38,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,6,1]]}},"URL":"https:\/\/doi.org\/10.1188\/22.cjon.313-317","relation":{},"ISSN":["1092-1095","1538-067X"],"issn-type":[{"value":"1092-1095","type":"print"},{"value":"1538-067X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,6,1]]}}}